News|Articles|November 6, 2023
Nitrosamine Impurities Deadline: Are You Compliant?
Author(s)Adare Pharma Solutions
A discussion of the FDA's guidance on nitrosamine impurities, various approaches for reducing the presence of impurities, and how Adare's unique nitrosamine mitigation process can help products achieve compliance.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
3
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
4
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
5